Drug Shortage Report for HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION
Report ID | 107741 |
Drug Identification Number | 01990748 |
Brand name | HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION |
Common or Proper name | Heparin |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | HEPARIN SODIUM |
Strength(s) | 2UNIT |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 18 x 500ML PLBG |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-03-02 |
Estimated end date | |
Actual end date | 2020-06-16 |
Shortage status | Resolved |
Updated date | 2020-06-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2020-06-17 | English | Compare |
v8 | 2020-06-16 | French | Compare |
v7 | 2020-06-16 | English | Compare |
v6 | 2020-03-04 | French | Compare |
v5 | 2020-03-04 | English | Compare |
v4 | 2020-03-04 | French | Compare |
v3 | 2020-03-04 | English | Compare |
v2 | 2020-03-04 | French | Compare |
v1 | 2020-03-04 | English | Compare |
Showing 1 to 9 of 9